CATHERINE WILLIAMS: Open Payments
NPI 1851870786 · LEESBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 26 payments from 7 companies in 2025. Trend: 2023 $212 · 2024 $227 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $187 |
| Novo Nordisk Inc | 8 | $156 |
| Amgen Inc. | 4 | $78 |
| Dexcom, Inc. | 1 | $40 |
| Lilly USA, LLC | 2 | $36 |
| Astellas Pharma US Inc | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
Products named: QULIPTA, OTEZLA, UBRELVY, Ozempic, Dexcom G6 Transmitter, VRAYLAR, Veozah, Wegovy.
Industry payments across VA — which companies pay providers there.
